Chi‐Jen Chu
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 42
- Hepatitis C virus research 23
- Liver Disease and Transplantation 15
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Epidemiology 19
- Liver Disease Diagnosis and Treatment 15
- Hepatitis B Virus Studies 11
- Co-authors
- Shou‐Dong Lee (29 shared papers)Han‐Chieh Lin (25 shared papers)Yi‐Hsiang Huang (25 shared papers)Fa‐Yauh Lee (10 shared papers)Che‐Chang Chan (12 shared papers)Erwin Sablon (1 shared paper)Anna S. Lok (1 shared paper)Munira Hussain (1 shared paper)
- Journals
- Journal of Gastroenterology and Hepatology (6 papers)Clinical Science (5 papers)Journal of Hepatology (2 papers)Liver International (2 papers)Digestive Diseases and Sciences (2 papers)
- Partner nations
- TaiwanUnited StatesVietnam
In The Last Decade
Chi‐Jen Chu
56 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 90
- Hepatology 612
- Epidemiology 567
- Gastroenterology 39
- Pharmacology 49
- Surgery 113
Countries citing papers authored by Chi‐Jen Chu
This map shows the geographic impact of Chi‐Jen Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Jen Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Jen Chu more than expected).
Fields of papers citing papers by Chi‐Jen Chu
This network shows the impact of papers produced by Chi‐Jen Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Jen Chu. The network helps show where Chi‐Jen Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Jen Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 160 | |
| 2 | 2016 | 126 | |
| 3 | 2003 | 85 | |
| 4 | 1997 | 50 | |
| 5 | 2002 | 37 | |
| 6 | 2001 | 34 | |
| 7 | 2012 | 34 | |
| 8 | 2000 | 30 | |
| 9 | 2005 | 26 | |
| 10 | 2010 | 26 | |
| 11 | 2016 | 23 | |
| 12 | 2010 | 23 | |
| 13 | 2016 | 22 | |
| 14 | 2016 | 22 | |
| 15 | Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha. | 2008 | 22 |
| 16 | 2011 | 21 | |
| 17 | 1999 | 18 | |
| 18 | Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease. | 2008 | 18 |
| 19 | 2008 | 17 | |
| 20 | 2019 | 15 |
About Chi‐Jen Chu
Chi‐Jen Chu is a scholar working on Hepatology, Epidemiology, Physiology, Biochemistry and Surgery, having authored 58 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (23 papers), Liver Disease and Transplantation (15 papers), Liver Disease Diagnosis and Treatment (15 papers), Hepatitis B Virus Studies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Nitric Oxide and Endothelin Effects (3 papers) and Alcoholism and Thiamine Deficiency (1 paper). The work is most often cited by research in Hepatology (612 citations), Epidemiology (567 citations), Gastroenterology (39 citations), Pharmacology (49 citations) and Surgery (113 citations). Chi‐Jen Chu has collaborated with scholars based in Taiwan, United States and Vietnam. Frequent co-authors include Shou‐Dong Lee, Han‐Chieh Lin, Yi‐Hsiang Huang, Fa‐Yauh Lee, Che‐Chang Chan, Erwin Sablon, Anna S. Lok, Munira Hussain, Ming-Chih Hou and Anna Suk‐Fong Lok. Their work appears in journals such as Journal of Gastroenterology and Hepatology, Clinical Science, Journal of Hepatology, Liver International and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.